Lineage Cell Therapeutics
Lineage Cell Therapeutics Logo
About Lineage Cell Therapeutics
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on developing novel cell therapies for neurological, ophthalmic, and oncological conditions. Its pipeline includes OpRegen, an allogeneic retinal pigment epithelium cell therapy for age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy for spinal cord injuries; and VAC2, a cell therapy for non-small cell lung cancer. The company also develops therapies for hearing loss and vision loss due to photoreceptor dysfunction. Lineage collaborates with partners to advance cell-based therapies and is headquartered in Carlsbad, California.
Address
2173 Salk Avenue, Suite 200
Carlsbad, 92008
United States
Year founded
1990
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
